Latest News

Final Results

RNS Number: 1074F Physiomics PLC 10 November 2015 Physiomics Plc ("Physiomics" or the "Company") Final Results for the year ended 30 June 2015 Chairman's Statement Summary of Results in the year ended 30 June 2015 The turnover of the Company was 235,486 (2014: 267,903). The operating loss reduced to 414,755 (2014: 465,265). On 30 June 2015 the surplus of ...

Physiomics identifies potential acquisition target

Physiomics has identified a number of potential acquisition targets, including one in particular where the synergy with its...

Strategic Update

RNS Number: 7601E Physiomics PLC 06 November 2015 Physiomics plc ("Physiomics") or (the "Company") Strategic Update Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to provide an update on its strategic direction. For some time the Company has been pursuing M&A targets, in particular oncology therapeutics companies...

PYC says 4th large pharma customer for Virtual Tumour

Physiomics has signed a new Virtual Tumour deal with a new pharmaceutical company, the 4th large pharma customer f...

All News

10-11-15Final ResultsRNS
06-11-15Physiomics identifies potential acquisition targetStockMarketWire
06-11-15Strategic UpdateRNS
12-10-15PYC says 4th large pharma customer for Virtual Tumour StockMarketWire
12-10-154th Large Pharma Customer for Virtual TumourRNS
09-10-15Physiomics inks extension for Virtual Tumour projectStockMarketWire
09-10-15Project extension with global pharma companyRNS
04-08-15Prof. Mark Middleton appointed to Physiomics SABRNS
29-04-15Holding(s) in CompanyRNS
22-04-15Virtual Tumour platform - AACR Annual Meeting 2015RNS
22-04-15Virtual Tumour platform - AACR Annual Meeting 2015RNS
26-03-15Issue of OptionsRNS
17-03-15Half Yearly ReportRNS
12-03-15Issue of EquityRNS
06-03-15Holding(s) in CompanyRNS
04-03-15Holding(s) in CompanyRNS
03-03-15FTSE ends lower as blue-chip trinity weighsStockMarketWire
03-03-15Physiomics' dealStockMarketWire
03-03-15First contract for clinical version of VirtuRNS
20-02-15Holding(s) in CompanyRNS
02-02-15Termination of Equity Swap AgreementRNS
15-12-14Result of AGMRNS
17-11-14FTSE falls as Astrazeneca, financials slip lowerStockMarketWire
12-11-14Operating losses fall at PhysiomicsStockMarketWire
12-11-14Final ResultsRNS
04-11-14FTSE up on financials as oily stocks feel Saudi pinchStockMarketWire
04-11-14Disclosure of Large Pharma partner Merck & CoRNS
27-10-14Physiomics extends deal with pharma partnerStockMarketWire
27-10-14Project extension with global pharma companyRNS
13-10-14Holding(s) in CompanyRNS
07-10-14Cardiotox Platform LaunchRNS
29-08-14Holding(s) in CompanyRNS
14-08-14Physiomics wins new deal with global pharmaStockMarketWire
14-08-14New deal with global pharmaRNS
24-07-14Physiomics raises up to £562,500StockMarketWire
24-07-14Issue of EquityRNS
26-06-14Holding(s) in CompanyRNS
12-06-14Physiomics in anticipated new collaboration with DiatechStockMarketWire
12-06-14Anticipated new collaboration with DiatechRNS
20-05-14Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory